Lobbying

Theratec's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q1 2023; the issues it reports most are Veterans and Defense.

Theratec

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Theratec lobbying by quarter
Theratec lobbying by quarter
QuarterAmountReports
Q1 2023$01
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Veterans$25K · 8 reports
  • Defense$5,000 · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE8 reports
  • Veterans Affairs, Dept of (VA)7 reports
  • HOUSE OF REPRESENTATIVES6 reports
  • Defense, Dept of (DOD)3 reports

Firms it paid

Firm
Terrapin Strategy$30K9 quarters

Former officials lobbying for it

Former position
JASON JACKSON FRYELegislative Director Tom Emmer (R-MN-06)Q4 2024

Lobbying reports

Filed by
25/04/07for Q1 2025Terrapin StrategyUnder $5,000
25/01/20for Q4 2024Terrapin StrategyUnder $5,000
24/10/11for Q3 2024Terrapin StrategyUnder $5,000
24/07/18for Q2 2024Terrapin StrategyUnder $5,000
24/04/26for Q1 2024Terrapin StrategyUnder $5,000
24/04/24for Q1 2024Terrapin StrategyUnder $5,000
24/01/17for Q4 2023Terrapin Strategy$10K
23/10/20for Q3 2023Terrapin Strategy$10K
23/07/21for Q2 2023Terrapin Strategy$10K
23/07/21for Q1 2023Terrapin StrategyUnder $5,000
23/07/20for Q1 2023Terrapin StrategyUnder $5,000